Pulike Biological Engineering Inc Class A 603566
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 19.92
- Day Range
- CNY 19.75–21.11
- 52-Week Range
- CNY 12.89–27.77
- Bid/Ask
- CNY 20.97 / CNY 20.98
- Market Cap
- CNY 7.26 Bil
- Volume/Avg
- 8.7 Mil / 3.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 56.77
- Price/Sales
- 5.90
- Dividend Yield (Trailing)
- 3.26%
- Dividend Yield (Forward)
- 3.26%
- Total Yield
- 3.39%
Company Profile
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,718
- Website
- http://www.pulike.com.cn
Comparables
Valuation
|
Metric
|
603566
|
300149
|
000403
|
|---|---|---|---|
Price/Earnings (Normalized) | 56.77 | — | 32.95 |
Price/Book Value | 2.52 | 1.94 | 2.80 |
Price/Sales | 5.90 | 2.52 | 8.41 |
Price/Cash Flow | 28.45 | 14.16 | 40.45 |
Price/Earnings
603566
300149
000403
Financial Strength
|
Metric
|
603566
|
300149
|
000403
|
|---|---|---|---|
Quick Ratio | 2.52 | 1.54 | 2.66 |
Current Ratio | 3.00 | 1.76 | 4.01 |
Interest Coverage | — | −30.81 | 88.68 |
Quick Ratio
603566
300149
000403
Profitability
|
Metric
|
603566
|
300149
|
000403
|
|---|---|---|---|
Return on Assets (Normalized) | 3.63% | −2.10% | 7.64% |
Return on Equity (Normalized) | 4.33% | −3.21% | 8.84% |
Return on Invested Capital (Normalized) | 4.16% | −2.01% | 7.59% |
Return on Assets
603566
300149
000403
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vyksbcyhp | Jlw | $567.0 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Pdddsyz | Zzbmwbt | $109.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bhlvpnsh | Lscgk | $105.3 Bil | |
MRNA
| Moderna Inc | Pfbkvll | Lndkq | $47.0 Bil | |
ARGX
| argenx SE ADR | Jqgsddmjj | Gqvt | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Rbfzgzvv | Rth | $22.1 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ykmyrtkpn | Gwnsxf | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Wplzthmjn | Snnxz | $15.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fhrmyhwcdf | Pznyt | $12.7 Bil | |
INCY
| Incyte Corp | Zjfywdxf | Dpmcpk | $12.0 Bil |